Simultaneous study of five candidate target antigens (CD20, CD22, CD33, CD52, HER2) for antibody-based immunotherapy in B-ALL: a monocentric study of 44 cases.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples